Results 51 to 60 of about 8,384 (181)
Appetite, 2022 This paper is based on a presentation given at the Annual Meeting of the Society for the Study of Ingestive Behavior in July 2021 and provides a personal view on some of the milestones in the discovery of amylin as a constituent of pancreatic islet amyloid deposits, as a pancreatic beta-cell hormone, and on its role in physiology and pathophysiology ...
openaire +2 more sources
Innovations in Obesity Treatment: Beyond Adipose Tissue Dysfunction
Obesity Reviews, EarlyView.Obesity drives chronic inflammation, insulin resistance, type 2 diabetes, and cancer development through adipocyte dysfunction. Addressing this multisystemic disorder requires integrated strategies beyond diet and exercise, such as thermogenesis activation via menthol or capsinoids and appetite control through GLP‐1/GIP agonists and neuromodulation to ...
Jesica Martínez‐Godfrey +7 more
wiley +1 more source
The Journal of Headache and PainBackground The upper cervical dorsal root ganglia (DRG) are important for the transmission of sensory information associated with the back of the head and neck, contributing to head pain.
Tayla A. Rees +5 more
doaj +1 more source
Obesity Reviews, EarlyView.ABSTRACT Introduction Pregnancy concurrent with incretin‐based medications is contraindicated due to unknown risk of teratogenicity, as is breastfeeding. The aim of this systematic scoping review was to investigate potential risks and benefits of incretin‐based medications in relation to preconception, pregnancy, and postnatal health, and to propose ...
Kate Maslin +19 more
wiley +1 more source
Type 2 Diabetes Mellitus: Molecular Pathogenesis and Therapeutic Interventions
MedComm, Volume 7, Issue 8, August 2026.This graphical summary illustrates the multiorgan therapeutic landscape for Type 2 diabetes mellitus (T2D), integrating molecular pathogenesis with modern treatment strategies. It depicts how current interventions, including SGLT2 inhibitors, GLP‐1 receptor agonists, and insulin secretagogues, target key organs—kidney, pancreas, gastrointestinal tract,
Shinuan Fei +9 more
wiley +1 more source
Zhongguo shiyan zhenduanxue, 2011 目的探讨胰淀素（amylin）在肥胖相关性肾病（ORG）发展过程中的作用。方法 14例经肾活检证实的ORG患者为观察组（ORG组）,选择同期经肾活检确诊为系膜增生性肾小球肾炎患者作为相关疾病对照组（NC）。20只Wis-tar大鼠,高脂饮食诱导ORG大鼠模型,成模后随机均分为模型对照组（NC）和Amylin组（Amylin）。采用ELISA法检测血清amylin;放射免疫法检测胰岛素水平;自动生化分析仪测定血糖、血脂;考马斯亮蓝方法检测24小时尿蛋白定量;免疫组化法检测肾小球内amylin的表达。结果 ...
刘声茂 +6 more
doaj
Human Amylin as a Novel Diagnostic Marker for Hypothyroidism in Iraqi Patients
مجلة بغداد للعلومAmylin is a peptide hormone that the pancreas cell secretes along with insulin. As a neuroendocrine hormone that sends a specific signal to the brain, amylin is essential for maintaining homeostasis in the metabolism.
Duha Khalil Ibrahim, layla othman
doaj +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6595-6606, August 2026.ABSTRACT Aims There is an unmet need for effective pharmacotherapy for obesity disease management in Japan. Survodutide is a novel glucagon receptor/glucagon‐like peptide‐1 receptor (GLP‐1R) dual agonist with the potential to induce greater weight reductions than GLP‐1R mono‐agonists. We report the design and baseline participant characteristics of the
Koutaro Yokote +10 more
wiley +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 7196-7206, August 2026.ABSTRACT Aims This Phase 1b, randomised, double‐blind clinical trial investigated the contribution of glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) to insulin sensitivity and secretion in people with type 2 diabetes (T2D) on metformin. Materials and Methods Participants were randomised to receive the long‐acting
Tim Heise +10 more
wiley +1 more source
Neuroscience ResearchThe pancreatic peptide amylin promotes negative energy balance in part through activation of amylin receptors (AmyRs) expressed in the ventral tegmental area (VTA), but studies have been limited to male rodents.
Tyler J. Gustafson +3 more
doaj +1 more source